Perfil
Mira Leiwant currently works at Anika Therapeutics, Inc., as Senior VP-Quality, Regulatory & Clinical Affairs.
Ms. Leiwant also formerly worked at LifeCell Corp., as Senior Director-Regulatory & Quality Engineering and BTG International, Inc., as Vice President-Regulatory Affairs.
Ms. Leiwant received her undergraduate degree in 1997 and graduate degree in 1998 from Cornell University.
Cargos activos de Mira Leiwant
| Empresas | Cargo | Inicio |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 14/10/2019 |
Antiguos cargos conocidos de Mira Leiwant.
| Empresas | Cargo | Fin |
|---|---|---|
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Consejero General | - |
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Corporate Officer/Principal | - |
Formación de Mira Leiwant.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Health Technology |
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Finance |
- Bolsa de valores
- Insiders
- Mira Leiwant
















